Inventor · disambiguated record
Anthony Letai
Also filed as: LETAI ANTHONY · LETAI ANTHONY G
14 granted patents·7 pending applications·232 citations·filing 2003–2025
93Inventor score
Files withDANA FARBER CANCER INST INC11CARDONE MICHAEL H2BROAD INST INC1DANA-FARBER CANCER INSTITUTE INC1EUTROPICS PHARMACEUTICALS INC1
Top patents by PatentIndex Score
21 records- 0198US9902759B2BH3 peptides and methods of use thereofDANA FARBER CANCER INST INC·Filed 2016·Granted Feb 27, 2018·25 cites·8 claims
- 0297US7868133B2BH3 peptides and method of use thereofDANA FARBER CANCER INST INC·Filed 2007·Granted Jan 11, 2011·46 cites·6 claims
- 0395US8168755B2Antibodies specific to heterodimers of Bcl-2 family and uses thereofCARDONE MICHAEL H·Filed 2009·Granted May 1, 2012·33 cites·3 claims
- 0494US9540674B2Methods of determining cellular chemosensitivityLETAI ANTHONY G·Filed 2012·Granted Jan 10, 2017·30 cites·10 claims
- 0593US8221966B2Methods of determining cellular chemosensitivityLETAI ANTHONY·Filed 2007·Granted Jul 17, 2012·43 cites·18 claims
- 0691US11215608B2Methods of determining cellular chemosensitivityDANA FARBER CANCER INST INC·Filed 2016·Granted Jan 4, 2022·4 cites·12 claims
- 0791US9856303B2BH3 peptides and method of use thereofKORSMEYER STANLEY J·Filed 2010·Granted Jan 2, 2018·25 cites·3 claims
- 0888US10761086B2High throughput BH3 profiling: a rapid and scalable technology to BH3 profile on low numbers of cellsDANA FARBER CANCER INST INC·Filed 2016·Granted Sep 1, 2020·6 cites·14 claims
- 0987US11225511B2BH3 peptides and methods of use thereofDANA FARBER CANCER INST INC·Filed 2018·Granted Jan 18, 2022·4 cites·18 claims
- 1087US10739333B2Methods of BH3 profilingDANA-FARBER CANCER INSTITUTE INC·Filed 2014·Granted Aug 11, 2020·7 cites·20 claims
- 1187US10393733B2Dynamic BH3 profilingDANA FARBER CANCER INST INC·Filed 2013·Granted Aug 27, 2019·9 cites·14 claims
- 1268US11867688B2High throughput BH3 profiling: a rapid and scalable technology to BH3 profile on low numbers of cellsDANA FARBER CANCER INST INC·Filed 2020·Granted Jan 9, 2024·0 cites·19 claims
- 1367US11867687B2Methods of BH3 profilingDANA FARBER CANCER INST INC·Filed 2020·Granted Jan 9, 2024·0 cites·15 claims
- 1466US2021255167A1Compositions and methods for assessing toxicity using dynamic bh3 profilingDANA FARBER CANCER INST INC·Filed 2021·Application pending·0 cites
- 1564US2004171809A1BH3 peptides and method of use thereofFiled 2003·Application pending·0 cites
- 1663US11815508B2Dynamic BH3 profilingDANA FARBER CANCER INST INC·Filed 2019·Granted Nov 14, 2023·0 cites·20 claims
- 1762US2014234867A1Antibodies Specific to Heterodimers of Bcl-2 Family and Uses ThereofEUTROPICS PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 1860US2017160267A9Methods of determining cellular chemosensitivityDANA FARBER CANCER INST INC·Filed 2016·Application pending·0 cites
- 1957US2012225794A1Antibodies Specific to Heterodimers of Bcl-2 Family and Uses ThereofCARDONE MICHAEL H·Filed 2012·Application pending·0 cites
- 2056US2025368608A1Selective hdac6 inhibitorROYAL COLLEGE SURGEONS IRELAND·Filed 2021·Application pending·0 cites
- 2150US2025255889A1Methods for treatment selection for chronic lymphocytic leukemia (cll)BROAD INST INC·Filed 2025·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Anthony Letai files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →